Browse and enrol in our EQA schemes
Explore our range of EQA schemes to support laboratory quality, accreditation, and compliance with international standards. Filter by category to find the right scheme for your testing services. Prefer a PDF?
Explore our range of EQA schemes to support laboratory quality, accreditation, and compliance with international standards. Filter by category to find the right scheme for your testing services. Prefer a PDF?
We couldn't find any schemes that match your search criteria. Please try again with different filters.
Assessment of FLT3-ITD, FLT3-TKD, IDH1 and NPM1 variant detection and clinical interpretation in AML testing.
Closes 1 Mar 2027
To be finalised
To be finalised
From £545
Methylation and copy number analysis for BWS and SRS testing.
Not available in China and Hong Kong in 2027 due to import restrictions
Closes 30 Nov 2026
January - March 2027
August 2027
From £467
Sponsored!
PIK3CA, AKT1 and PTEN gene testing in breast cancer (FFPE)
Closes 28 Feb 2027
June - August 2027
December 2027 - January 2028
From £310
Sponsored!
ESR1 and PIK3CA testing in cfDNA (plasma) for metastatic breast cancer. This EQA is sponsored.
Closes 28 Feb 2027
September - November 2027
May - June 2028
From £310
Panel testing for Cardiac disorders (targeted NGS/ virtual panel /clinical exome / WES / WGS). This EQA has options for Arrythmia panel, Cardiomyopathy panel, and all Cardiac Disorders.
Closes 30 Nov 2026
January - March 2027
August 2027
From £467
EQA for quality and quantity of cfDNA extracted from plasma. There are two rounds of EQA per year which need to be purchased separately. This EQA will be distributed in March 2027. This EQA is sponsored.
Closes 30 Dec 2026
March - April 2027
Aug-27
Free
EQA for quality and quantity of cfDNA extracted from plasma. There are two rounds of EQA per year which need to be purchased separately. This EQA will be distributed in Sept 2027. This EQA is sponsored.
Closes 28 Feb 2027
September - October 2027
February 2028
Free
PMP22 deletion/duplication testing for CMT/HNPP, this EQA has options for PMP22 targeted testing and panel testing for CMT/HNPP associated genes (Germline DNA).
CMT targeted option: Not available in China and Hong Kong in 2027 due to import restrictions.
Closes 30 Nov 2026
January - March 2027
August 2027
From £467
KRAS, NRAS, BRAF and PIK3CA gene testing in colorectal cancer (FFPE).
Closes 28 Feb 2027
June - August 2027
December 2027 - January 2028
From £681
Sponsored!
Identification of different types of variants and genomic signatures by CGP in solid tumour (FFPE). This is a genotyping EQA only.
Closes 1 Mar 2027
June - August 2027.
December 2027 - January 2028
From £310
CYP21A2 testing for Congenital Adrenal Hyperplasia (CAH) (germline DNA testing)
Closes 30 Nov 2026
January - March 2027
August 2027
From £467
Point-of-care molecular testing (POCT) of CYP2C19 for optimisation of antiplatelet therapy (Artificial Buccal swabs)
Closes 22 Oct 2027
4 weeks after sample dispatch
N/A
From £1200
CFTR testing for Cystic Fibrosis (germline DNA testing). To participate in EQA for Cystic Fibrosis, please go to our partner organisation’s (CF Network) website (https://eqascheme.org)
N/A
N/A
Free
One set of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Closing soon
Closes today
Not applicable
Not applicable
From £890
Two sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Closing soon
Closes today
Not applicable
Not applicable
From £1115
Three sets of 8 patient-like swab-based materials designed to help implement and verify POCT devices for CYP2C19 testing. See https://www.emqn.org/our-eqa-schemes/poct/ for more information.
Closing soon
Closes today
Not applicable
Not applicable
From £1420
Express your interest in ''.